Working… Menu

Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00080886
Recruitment Status : Completed
First Posted : April 8, 2004
Last Update Posted : January 24, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
R. Gregory Bociek, MD, University of Nebraska

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2005
Actual Study Completion Date : March 2015